HCP Live March 30, 2024
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE

In this episode, hosts discuss GLP-1 RA use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and practical application of artificial intelligence into care.

In the third and final recap episode from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes, hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into a series of topics from the meeting, including GLP-1 receptor agonist use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and application of artificial intelligence into care.

For more on ATTD 2024, check out our other ATTD 2024 episodes on All Things Automated Insulin Delivery...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Digital Health, Patient / Consumer, Provider, Technology, Trends, Wearables
Related Articles:
Opinion: Readers respond to funding academic medical centers, the ‘residency research arms race,’ and more
How to prepare your workforce to think like AI pros
Confronting Addiction From Prevention to Recovery
Why Training and Development Programs are Vital for Older Healthcare Workers
Telehealth, Hybrid Care Increase EHR Strain For Doctors

Share This Article